Loading...
State-of-the-art treatment of metastatic renal cell carcinoma
Targeted therapy has greatly changed the way in which metastatic renal cell carcinoma (rcc) is treated. Agents that inhibit the vascular endothelial growth factor and mammalian target of rapamycin pathways that otherwise lead to angiogenesis have now become the standard of care. Much research into t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Multimed Inc.
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2687801/ https://ncbi.nlm.nih.gov/pubmed/19478897 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|